Citation Impact
Citing Papers
Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction
2008 Standout
Glioblastoma Cells Require Glutamate Dehydrogenase to Survive Impairments of Glucose Metabolism or Akt Signaling
2009
TKTL1 Is Activated by Promoter Hypomethylation and Contributes to Head and Neck Squamous Cell Carcinoma Carcinogenesis through Increased Aerobic Glycolysis and HIF1α Stabilization
2010
Transient Ablation of Regulatory T cells Improves Antitumor Immunity in Colitis-Associated Colon Cancer
2014 StandoutNobel
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
2010 Standout
NOTCH Signaling Is Required for Formation and Self-Renewal of Tumor-Initiating Cells and for Repression of Secretory Cell Differentiation in Colon Cancer
2010 StandoutNobel
Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
2010 StandoutNobel
Genetic Influences on Brain Gene Expression in Rats Selected for Tameness and Aggression
2014 StandoutNobel
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Tp53-induced Glycolysis and Apoptosis Regulator (TIGAR) Protects Glioma Cells from Starvation-induced Cell Death by Up-regulating Respiration and Improving Cellular Redox Homeostasis
2012
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Hallmarks of Cancer: The Next Generation
2011 Standout
Analysis of Hypoxia-Induced Metabolic Reprogramming
2014 StandoutNobel
Hypoxia-Inducible Factors and the Response to Hypoxic Stress
2010 Standout
Regulation of the Warburg Effect in Early-Passage Breast Cancer Cells
2008
The Transcription Factor Myc Controls Metabolic Reprogramming upon T Lymphocyte Activation
2011 Standout
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
2003 Standout
Ferroptosis as a p53-mediated activity during tumour suppression
2015 StandoutNature
Brick by brick: metabolism and tumor cell growth
2008
Targeting HIF-1 for cancer therapy
2003 StandoutNobel
A Comparison of Brain Gene Expression Levels in Domesticated and Wild Animals
2012 StandoutNobel
ROS homeostasis and metabolism: a critical liaison for cancer therapy
2016
Association of BRAFV600EMutation with Poor Clinical Prognostic Factors and US Features in Korean Patients with Papillary Thyroid Microcarcinoma
2009
Metabolic Reprogramming by the PI3K-Akt-mTOR Pathway in Cancer
2016
In vivo assessment of vascular endothelial growth factor-induced angiogenesis
1999
Cancer despite immunosurveillance: immunoselection and immunosubversion
2006
Cancer drug resistance: an evolving paradigm
2013 Standout
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
Otto Warburg's contributions to current concepts of cancer metabolism
2011 Standout
Resistance mechanisms to cancer chemotherapy
2008
The biology and function of fibroblasts in cancer
2016 Standout
Causes and Consequences of Increased Glucose Metabolism of Cancers
2008
SDH5 Mutations and Familial Paraganglioma: Somewhere Warburg is Smiling
2009 StandoutNobel
Targeting metabolic transformation for cancer therapy
2010
The combination of silencing BAG3 and inhibition of the JNK pathway enhances hyperthermia sensitivity in human oral squamous cell carcinoma cells
2013
Tumor Cell Metabolism: Cancer's Achilles' Heel
2008 Standout
Transketolase‐like protein 1 (TKTL1) is required for rapid cell growth and full viability of human tumor cells
2008
Insulin and insulin-like growth factor signalling in neoplasia
2008 Standout
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
2008 Standout
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
2017 Standout
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Regulation of cancer cell metabolism
2011 Standout
Interleukin‐10 in viral diseases and cancer: exiting the labyrinth?
2004
Metabolic Regulation by p53 Family Members
2013
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
2010 Standout
The molecular determinants of de novo nucleotide biosynthesis in cancer cells
2009
The role of tumour–stromal interactions in modifying drug response: challenges and opportunities
2013
The Emerging Hallmarks of Cancer Metabolism
2016 Standout
Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism☆
2009
Dysregulated pH: a perfect storm for cancer progression
2011 Standout
Colon Cancer Stem Cells Dictate Tumor Growth and Resist Cell Death by Production of Interleukin-4
2007
Gold-nanorods-siRNA nanoplex for improved photothermal therapy by gene silencing
2015
Genomic instability — an evolving hallmark of cancer
2010 Standout
The PI3K Pathway in Human Disease
2017 Standout
c-FLIP inhibits chemotherapy-induced colorectal cancer cell death
2005
Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy
2006 Standout
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Calreticulin exposure dictates the immunogenicity of cancer cell death
2006 Standout
Selective Expansion of Chimeric Antigen Receptor-targeted T-cells with Potent Effector Function using Interleukin-4
2010
Glycosylation in cancer: mechanisms and clinical implications
2015 Standout
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism
2009 StandoutNature
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
2009 Standout
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
Clues from cell metabolism
2010 StandoutNatureNobel
Transketolase protein TKTL1 overexpression: A potential biomarker and therapeutic target in breast cancer
2007
Alternative activation of tumor-associated macrophages by IL-4
2010
Muc1 Immunotherapy
2010
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma
2008 StandoutNobel
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Human TKTL1 implies greater neurogenesis in frontal neocortex of modern humans than Neanderthals
2022 StandoutScienceNobel
Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy.
2002
Detection of in vivo P-glycoprotein inhibition by PSC 833 using Tc-99m sestamibi.
1997
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Ammonium Trichloro(dioxoethylene-o,o′)tellurate (AS101) Sensitizes Tumors to Chemotherapy by Inhibiting the Tumor Interleukin 10 Autocrine Loop
2004
A key role for transketolase-like 1 in tumor metabolic reprogramming
2016
CD4+CD25+ T Regulatory Cells Dominate Multiple Immune Evasion Mechanisms in Early but Not Late Phases of Tumor Development in a B Cell Lymphoma Model
2007
“Inverse Drug Discovery” Strategy To Identify Proteins That Are Targeted by Latent Electrophiles As Exemplified by Aryl Fluorosulfates
2017 StandoutNobel
Works of M Zerilli being referenced
MUC1 Oncoprotein Promotes Refractoriness to Chemotherapy in Thyroid Cancer Cells
2007
Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted
2006
Technetium-99m sestamibi: an indicator of breast cancer invasiveness
1994
Increased expression of transketolase‐like‐1 in papillary thyroid carcinomas smaller than 1.5 cm in diameter is associated with lymph‐node metastases
2008
Thyroid cancer resistance to chemotherapeutic drugs via autocrine production of interleukin-4 and interleukin-10.
2003
PED Mediates AKT-Dependent Chemoresistance in Human Breast Cancer Cells
2005
Autocrine Production of Interleukin-4 and Interleukin-10 Is Required for Survival and Growth of Thyroid Cancer Cells
2006
IL-4 Protects Tumor Cells from Anti-CD95 and Chemotherapeutic Agents via Up-Regulation of Antiapoptotic Proteins
2004
The Antiapoptotic Protein BAG3 Is Expressed in Thyroid Carcinomas and Modulates Apoptosis Mediated by Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand
2006